glp 1 weight loss clinical trials How Did Diabetes Medications Become Meds? Beyond Journal Club on SURMOUNT-1 Trial – Core IM Podcast We are now enrolling for

Your Time

Eli Lilly and Company has announced positive topline results for the first oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist, taken without food and water restrictions, to successfully complete a Phase III trial

The findings at the University of Colorado Anschutz, shared with the Post , were made as researchers studied young women taking GLP-1 medications to treat a common hormonal condition, PCOS, recently renamed to polyendocrine metabolic ovarian syndrome or PMOS

Shares in the correct outcome are redeemable for $1 each upon market resolution

When light (specifically blue light) hits your eyes in the morning, it triggers the breakdown of melatonin and stops pineal gland production for the day